Literature DB >> 31708054

Childhood-Onset Schizophrenia and Early-onset Schizophrenia Spectrum Disorders: An Update.

David I Driver1, Shari Thomas2, Nitin Gogtay3, Judith L Rapoport4.   

Abstract

The clinical severity, impact on development, and poor prognosis of childhood-onset schizophrenia may represent a more homogeneous group. Positive symptoms in children are necessary for the diagnosis, and hallucinations are more often multimodal. In healthy children and children with a variety of other psychiatric illnesses, hallucinations are not uncommon and diagnosis should not be based on these alone. Childhood-onset schizophrenia is an extraordinarily rare illness that is poorly understood but seems continuous with the adult-onset disorder. Once a diagnosis is confirmed, aggressive medication treatment combined with family education and individual counseling may prevent further deterioration. Published by Elsevier Inc.

Entities:  

Keywords:  Childhood psychosis; Childhood-onset schizophrenia; Schizophrenia

Mesh:

Substances:

Year:  2020        PMID: 31708054     DOI: 10.1016/j.chc.2019.08.017

Source DB:  PubMed          Journal:  Child Adolesc Psychiatr Clin N Am        ISSN: 1056-4993


  14 in total

1.  Effect of Integrated Psychobehavioral Care on Emotional-Behavioral Responses, Cognitive Changes in Outpatients with Schizophrenia Followed Up: Based on a Prospective Randomized Controlled Study.

Authors:  Yao Yao; Yali Xu; Hongyan Guo; Kunxiu Han; Zhuo Dai
Journal:  Comput Math Methods Med       Date:  2022-06-16       Impact factor: 2.809

2.  Alternatives to Gold Standard Diagnostic Tools for Distinguishing "Natural Kinds" on the Autism Spectrum.

Authors:  Anne Philippe
Journal:  Front Psychiatry       Date:  2022-06-06       Impact factor: 5.435

3.  Time to Clinical Response in the Treatment of Early Onset Schizophrenia Spectrum Disorders Study.

Authors:  Jerome H Taylor; Scott Appel; Matthew Eli; Aaron Alexander-Bloch; Lawrence Maayan; Raquel E Gur; Michael H Bloch
Journal:  J Child Adolesc Psychopharmacol       Date:  2020-07-01       Impact factor: 2.576

4.  Retrospective Review of Clozapine Use in Children and Adolescents.

Authors:  Ardelle Komaryk; Dean Elbe; Leah Burgess
Journal:  J Can Acad Child Adolesc Psychiatry       Date:  2021-02-01

5.  Clinical high-risk criteria of psychosis in 8-17-year-old community subjects and inpatients not suspected of developing psychosis.

Authors:  Frauke Schultze-Lutter; Petra Walger; Maurizia Franscini; Nina Traber-Walker; Naweed Osman; Helene Walger; Benno G Schimmelmann; Rahel Flückiger; Chantal Michel
Journal:  World J Psychiatry       Date:  2022-03-19

6.  Enhanced Resting-State Functional Connectivity of the Nucleus Accumbens in First-Episode, Medication-Naïve Patients With Early Onset Schizophrenia.

Authors:  Xiaohua Cao; Qiang Li; Sha Liu; Zexuan Li; Yanfang Wang; Long Cheng; Chengxiang Yang; Yong Xu
Journal:  Front Neurosci       Date:  2022-03-25       Impact factor: 4.677

7.  Gender differences in the use of atypical antipsychotics in early-onset schizophrenia: a nationwide population-based study in Brazil.

Authors:  Izabela Fulone; Marcus Tolentino Silva; Luciane Cruz Lopes
Journal:  BMC Psychiatry       Date:  2021-06-29       Impact factor: 3.630

Review 8.  The Phenomenology and Neurobiology of Visual Distortions and Hallucinations in Schizophrenia: An Update.

Authors:  Steven M Silverstein; Adriann Lai
Journal:  Front Psychiatry       Date:  2021-06-11       Impact factor: 4.157

9.  [Neurodevelopmental Disorders, Psychiatric Comorbidities and Associated Pathologies in Patients with Childhood-Onset Schizophrenia and Premorbid Autistic Symptoms.]

Authors:  A Fernandez; M Pasquet-Levy; G Laure; S Thümmler; F Askenazy
Journal:  Can J Psychiatry       Date:  2021-02-10       Impact factor: 5.321

10.  Critical appraisal and comparison of recommendations of clinical practice guidelines for treatment of schizophrenia in children and adolescents: a methodological survey protocol.

Authors:  Maíra Ramos Alves; Cristiane de Cássia Bergamaschi; Flávia Blaseck Sorrilha; Izabela Fulone; Silvio Barberato-Filho; Rejane Coan Ferretti Mayer; Daniela Oliveira de Melo; Luciane Lopes
Journal:  BMJ Open       Date:  2020-09-16       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.